10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG)

Historical Holders from Q3 2019 to Q4 2025

Symbol
TXG on Nasdaq
Type / Class
Equity / Class A common stock, par value $0.00001 per share
Shares outstanding
114,401,766
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares, excl. options
123,141,566
Holdings value
$1,439,488,398
% of all portfolios
0%
Number of holders
310
Number of buys
163
Number of sells
131
Average buys %
+0%
Average sells %
-0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
VANGUARD GROUP INC 12% $155,176,941 13,274,332 The Vanguard Group 30 Sep 2025
ARK Investment Management LLC 10% -12% $138,963,659 -$11,202,726 11,887,396 -7.5% ARK Investment Management LLC 30 Sep 2025
FMR LLC 8.1% -22% $108,527,302 -$26,256,126 9,283,773 -19% FMR LLC 30 Sep 2025
BlackRock, Inc. 7.6% $98,391,045 8,496,636 BlackRock, Inc. 30 Jun 2025
Sumitomo Mitsui Trust Group, Inc. 4.7% -14% $62,906,450 -$7,397,081 5,381,219 -11% Sumitomo Mitsui Trust Group, Inc. 30 Sep 2025
Amova Asset Management Americas, Inc. 4.7% -14% $62,855,762 -$7,397,081 5,376,883 -11% Amova Asset Management Americas, Inc. 30 Sep 2025
MILLENNIUM MANAGEMENT LLC 2.7% -48% $36,913,960 -$29,821,474 3,060,859 -45% Millennium Management LLC 30 Jun 2025
As of 30 Sep 2025 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) has 310 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 123,141,566 shares of the company stock as of 30 Sep 2025.

Institutional Holders of 10x Genomics, Inc. - Class A common stock, par value $0.00001 per share (TXG) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price Investors
2025 Q4 14,703 $239,806 -$16,278 $16.31 2
2025 Q3 123,141,566 $1,439,488,398 +$7,700,951 $11.69 310
2025 Q2 122,631,794 $1,420,549,489 +$119,573,048 $11.58 293
2025 Q1 113,813,127 $993,375,835 +$50,874,984 $8.73 269
2024 Q4 104,507,907 $1,500,773,196 -$41,937,351 $14.36 270
2024 Q3 104,345,431 $2,355,358,198 -$6,296,831 $22.58 258
2024 Q2 105,353,108 $2,048,895,776 +$7,101,276 $19.45 254
2024 Q1 102,897,655 $3,861,610,085 +$222,058,012 $37.53 280
2023 Q4 95,956,168 $5,370,151,466 +$202,330,286 $55.96 267
2023 Q3 90,883,461 $3,748,861,587 +$66,054,684 $41.25 252
2023 Q2 89,127,845 $4,977,465,562 -$57,613,061 $55.84 269
2023 Q1 90,187,979 $5,027,414,812 +$211,396,981 $55.79 255
2022 Q4 87,545,856 $3,190,400,302 +$104,674,768 $36.44 253
2022 Q3 86,068,255 $2,449,753,227 -$43,840,073 $28.48 208
2022 Q2 86,085,516 $3,909,380,180 +$83,806,084 $45.25 228
2022 Q1 82,769,403 $6,293,794,627 -$74,133,769 $76.07 286
2021 Q4 79,764,587 $11,861,468,865 +$65,047,101 $148.96 347
2021 Q3 78,759,967 $11,461,957,413 +$127,530,777 $145.58 317
2021 Q2 77,884,791 $15,246,137,868 +$1,517,689,271 $195.82 332
2021 Q1 70,505,001 $12,760,866,584 +$832,242,795 $181.00 310
2020 Q4 66,229,914 $9,377,686,882 -$749,751,524 $141.60 299
2020 Q3 69,088,795 $8,545,655,879 +$1,071,434,021 $124.68 215
2020 Q2 61,004,107 $5,448,595,110 +$1,160,387,284 $89.31 141
2020 Q1 38,929,050 $2,426,163,019 +$612,574,707 $62.32 102
2019 Q4 30,795,732 $2,348,169,329 +$108,804,039 $76.25 85
2019 Q3 22,339,937 $1,125,942,955 +$1,125,942,955 $50.40 92